Cited by 168Atherosclerosis and Cardiovascular DiseasesCardiac Imaging and DiagnosticsCerebrovascular and Carotid Artery Diseases

High-Resolution Magnetic Resonance Imaging Enhanced With Superparamagnetic Nanoparticles Measures Macrophage Burden in Atherosclerosis

Open access
Morishige, Kunio, Kacher, Daniel F., Libby, Peter, Josephson, Lee, Ganz, Peter, Weissleder, Ralph, Aikawa, Masanori·2010·Circulation

Abstract

Background—: Macrophages contribute to the progression and acute complications of atherosclerosis. Macrophage imaging may serve as a biomarker to identify subclinical inflamed lesions, to predict future risk, and to aid in the assessment of novel therapies. Methods and Results—: To test the hypothesis that nanoparticle-enhanced, high-resolution magnetic resonance imaging (MRI) can measure plaque macrophage accumulation, we used 3-T MRI with a macrophage-targeted superparamagnetic nanoparticle preparation (monocrystalline iron oxide nanoparticles-47 [MION-47]) in cholesterol-fed New Zealand White rabbits 6 months after balloon injury. In vivo MRI visualized thickened abdominal aortas on both T1- and T2-weighted spin-echo images (T1 spin echo, 20 axial slices per animal; T2 spin echo, 28 slices per animal). Seventy-two hours after MION-47 injection, aortas exhibited lower T2 signal intensity compared with before contrast imaging (signal intensity ratio, aortic wall/muscle: before, 1.44±0.26 versus after, 0.95±0.22; 164 slices; P <0.01), whereas T1 spin echo images showed no significant change. MRI on ex vivo specimens provided similar results. Histological studies colocalized iron accumulation with immunoreactive macrophages in atheromata. The magnitude of signal intensity reduction on T2 spin echo in vivo images further correlated with macrophage areas in situ (150 slices; r =0.73). Treatment with rosuvastatin for 3 months yielded diminished macrophage content ( P <0.05) and reversed T2 signal intensity changes ( P <0.005). Signal changes in rosuvastatin-treated rabbits correlated with reduced macrophage burden ( r =0.73). In vitro validation studies showed concentration-dependent MION-47 uptake by human primary macrophages. Conclusion—: The magnitude of T2 signal intensity reduction in high-resolution MRI after administration of superparamagnetic phagocytosable nanoparticles can assess macrophage burden in atheromata, providing a clinically translatable tool to identify inflamed plaques and to monitor therapy-mediated changes in plaque inflammation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.109.891804

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SPIO facilitate internalization of nanoparticles in macrophages, as evidenced by incorporation of monocrystalline iron oxide particles in atherosclerotic macrophages.

    “Furthermore, superparamagnetic iron oxide nanoparticles (SPIO) facilitate the internalization of nanoparticles in macrophages, as evidenced by the incorporation of monocrystalline iron oxide particles in atherosclerotic macrophages.153”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Morishige, K., Kacher, D. F., Libby, P., Josephson, L., Ganz, P., Weissleder, R., & Aikawa, M.
Affiliations
Brigham and Women's Hospital (US)
Venue
Circulation
Published
2010-10-26
Volume
122
Issue
17
Pages
1707-1715
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2004937569
Cited by
168
References
50
Citations by year
2026: 2 · 2025: 1 · 2024: 7 · 2023: 4 · 2022: 9 · 2021: 11 · 2020: 6 · 2019: 9 · 2018: 8 · 2017: 8 · 2016: 12 · 2015: 16 · 2014: 16 · 2013: 14 · 2012: 26
FWCI
8.10
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • AstraZeneca
  • Uehara Memorial Foundation
  • Japan Heart Foundation
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (HL-80472, U01HL080731, HL 66086, R01HL078641, HL-078641, HL 56895, R29HL056895, R01HL080472, R01HL066086, R01HL056895)
  • National Center for Research Resources (U41RR019703, U41 RR19703)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cerebrovascular and Carotid Artery Diseases
Keywords
atherosclerosis, superparamagnetic iron oxide nanoparticles, plaque inflammation, T2 signal intensity, high-resolution MRI, rosuvastatin, balloon injury, rabbit model, phagocytosis, iron accumulation
MeSH terms
Rosuvastatin Calcium, Animals, Aorta, Abdominal, Cholesterol, Dietary, Disease Models, Animal, Fluorobenzenes, Macrophages, Magnetic Resonance Imaging, Male, Pyrimidines, Rabbits, Sulfonamides, Treatment Outcome, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Atherosclerosis, Ferrosoferric Oxide, Nanoparticles, Metal Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review